123 related articles for article (PubMed ID: 15167009)
1. Deregulation of the G1 to S-phase cell cycle checkpoint is involved in the pathogenesis of human osteosarcoma.
López-Guerrero JA; López-Ginés C; Pellín A; Carda C; Llombart-Bosch A
Diagn Mol Pathol; 2004 Jun; 13(2):81-91. PubMed ID: 15167009
[TBL] [Abstract][Full Text] [Related]
2. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons.
Wei G; Lonardo F; Ueda T; Kim T; Huvos AG; Healey JH; Ladanyi M
Int J Cancer; 1999 Jan; 80(2):199-204. PubMed ID: 9935200
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines.
Park YB; Park MJ; Kimura K; Shimizu K; Lee SH; Yokota J
Cancer Genet Cytogenet; 2002 Mar; 133(2):105-11. PubMed ID: 11943335
[TBL] [Abstract][Full Text] [Related]
4. Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone.
Niini T; Lahti L; Michelacci F; Ninomiya S; Hattinger CM; Guled M; Böhling T; Picci P; Serra M; Knuutila S
Genes Chromosomes Cancer; 2011 May; 50(5):291-306. PubMed ID: 21254299
[TBL] [Abstract][Full Text] [Related]
5. Frequent deregulation of p16 and the p16/G1 cell cycle-regulatory pathway in neuroblastoma.
Diccianni MB; Omura-Minamisawa M; Batova A; Le T; Bridgeman L; Yu AL
Int J Cancer; 1999 Jan; 80(1):145-54. PubMed ID: 9935245
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL
Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171
[TBL] [Abstract][Full Text] [Related]
7. Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma.
Benassi MS; Molendini L; Gamberi G; Magagnoli G; Ragazzini P; Gobbi GA; Sangiorgi L; Pazzaglia L; Asp J; Brantsing C; Picci P
Cancer; 2001 Dec; 92(12):3062-7. PubMed ID: 11753985
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.
Ichimura K; Bolin MB; Goike HM; Schmidt EE; Moshref A; Collins VP
Cancer Res; 2000 Jan; 60(2):417-24. PubMed ID: 10667596
[TBL] [Abstract][Full Text] [Related]
10. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
[TBL] [Abstract][Full Text] [Related]
11. Altered G1 phase regulation in osteosarcoma.
Benassi MS; Molendini L; Gamberi G; Sollazzo MR; Ragazzini P; Merli M; Magagnoli G; Sangiorgi L; Bacchini P; Bertoni F; Picci P
Int J Cancer; 1997 Oct; 74(5):518-22. PubMed ID: 9355974
[TBL] [Abstract][Full Text] [Related]
12. Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
Naka T; Boltze C; Kuester D; Schulz TO; Schneider-Stock R; Kellner A; Samii A; Herold C; Ostertag H; Roessner A
Cancer; 2005 Sep; 104(6):1255-63. PubMed ID: 16078265
[TBL] [Abstract][Full Text] [Related]
13. Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease.
Jardin F; Callanan M; Penther D; Ruminy P; Troussard X; Kerckaert JP; Figeac M; Parmentier F; Rainville V; Vaida I; Bertrand P; Duval AB; Picquenot JM; Chaperot L; Marolleau JP; Plumas J; Tilly H; Bastard C
Leukemia; 2009 Apr; 23(4):698-707. PubMed ID: 19158833
[TBL] [Abstract][Full Text] [Related]
14. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
[TBL] [Abstract][Full Text] [Related]
15. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
[TBL] [Abstract][Full Text] [Related]
16. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
17. The Pezcoller lecture: cancer cell cycles revisited.
Sherr CJ
Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.
Park HR; Jung WW; Bertoni F; Bacchini P; Park JH; Kim YW; Park YK
Pathol Res Pract; 2004; 200(6):439-45. PubMed ID: 15310147
[TBL] [Abstract][Full Text] [Related]
19. G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder.
Niehans GA; Kratzke RA; Froberg MK; Aeppli DM; Nguyen PL; Geradts J
Br J Cancer; 1999 Jun; 80(8):1175-84. PubMed ID: 10376969
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma.
Tsuchiya T; Sekine K; Hinohara S; Namiki T; Nobori T; Kaneko Y
Cancer Genet Cytogenet; 2000 Jul; 120(2):91-8. PubMed ID: 10942797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]